Published ahead of print on May 11, 2007, doi:10.1164/rccm.200610-1427OC
Am. J. Respir. Crit. Care Med., Volume 176, Number 3, August 2007, 231-237
A more recent version of this article appeared on August 1, 2007
Submitted on October 5, 2006
Accepted on May 10, 2007
The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomised Controlled Trial
Dominick E Shaw1, Mike A Berry1, Mike Thomas2, Ruth H Green1, Chris E Brightling1, Andrew J Wardlaw1, and Ian D Pavord1*
1 Department of Respiratory Medicine and Thoracic Surgery, Institute for Lung Health, Glenfield Hospital, Leicester, Leicestershire, United Kingdom,
2 Department of General Practice, University of Aberdeen, Aberdeen, Aberdeenshire, United Kingdom
* To whom correspondence should be addressed. E-mail: ian.pavord{at}uhl-tr.nhs.uk.
Rationale: Current asthma guidelines recommend adjusting anti-inflammatory treatment on the basis of the results of lung function tests and symptom assessment, neither of which are closely associated with airway inflammation.
Objectives: We tested the hypothesis that titrating corticosteroid dose using the concentration of exhaled nitric oxide in exhaled breath (FENO) results in fewer asthma exacerbations and more efficient use of corticosteroids, when compared to traditional management.
Methods: 118 participants with a primary care diagnosis of asthma were randomised to a single blind trial of corticosteroid therapy based on either FENO measurements (n = 58) or British Thoracic Society guidelines (n = 60). Participants were assessed monthly for 4 months and then two monthly for a further 8 months. The primary outcome was the number of severe asthma exacerbations. Analyses were by intention to treat.
Measurements and Main Results: The estimated mean (SD) exacerbation frequency was 0.33/patient/year (0.69) in the FENO group and 0.42 (0.79) in the control group (mean difference -21% [95% CI -57% to 43%] p=0.43). Overall the FENO group used 11% more inhaled corticosteroid ([95% CI -17% to 42%] p=0.40), although the final daily dose of inhaled corticosteroid was lower in the FENO group (557µg vs. 895µg, mean difference 338µg [95% CI -640 to -37] p=0.028).
Conclusion: An asthma treatment strategy based on the measurement of exhaled nitric oxide did not result in a large reduction in asthma exacerbations or in the total amount of inhaled corticosteroid therapy used over 12 months, when compared with current asthma guidelines.
www.controlled-trials.com i.d. = ISRCTN08067387
Key words: asthma, asthma exacerbations, exhaled nitric oxide, airway inflammation
This article has been cited by other articles:

|
 |

|
 |
 
O. Holz and H. Magnussen
Cutoff Values for FENO-Guided Asthma Management
Am. J. Respir. Crit. Care Med.,
August 1, 2009;
180(3):
281 - 282.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al.
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice
Am. J. Respir. Crit. Care Med.,
July 1, 2009;
180(1):
59 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michils, R. Louis, R. Peche, S. Baldassarre, and A. Van Muylem
Exhaled nitric oxide as a marker of asthma control in smoking patients
Eur. Respir. J.,
June 1, 2009;
33(6):
1295 - 1301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Shaw
Exhaled nitric oxide: time to employ or make redundant?
Chronic Respiratory Disease,
February 1, 2009;
6(1):
3 - 4.
[PDF]
|
 |
|

|
 |

|
 |
 
G. Rodway, J Choi, L. Hoffman, and J. Sethi
Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications
Chronic Respiratory Disease,
February 1, 2009;
6(1):
19 - 29.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Stick and P. Franklin
NO More Dogma
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
87 - 88.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Taylor
Exhaled Nitric Oxide: Still Alive, Not Laid to Rest
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
88 - 89.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. de Jongste, S. Carraro, W. C. Hop, the CHARISM Study Group, and E. Baraldi
Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma
Am. J. Respir. Crit. Care Med.,
January 15, 2009;
179(2):
93 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D R Taylor and I D Pavord
Biomarkers in the assessment and management of airways diseases
Postgrad. Med. J.,
December 1, 2008;
84(998):
628 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Malerba, B. Ragnoli, A. Radaeli, and C. Tantucci
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma
Chest,
October 1, 2008;
134(4):
733 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lara, S. B. Khatri, Z. Wang, S. A. A. Comhair, W. Xu, R. A. Dweik, M. Bodine, B. S. Levison, J. Hammel, E. Bleecker, et al.
Alterations of the Arginine Metabolome in Asthma
Am. J. Respir. Crit. Care Med.,
October 1, 2008;
178(7):
673 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Haldar, I. D. Pavord, D. E. Shaw, M. A. Berry, M. Thomas, C. E. Brightling, A. J. Wardlaw, and R. H. Green
Cluster Analysis and Clinical Asthma Phenotypes
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
218 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michils, R. Peche, S. Baldassarre, Z. Mourid, and A. Van Muylem
Comparisons between portable and chemoluminescence exhaled nitric oxide measurements
Eur. Respir. J.,
July 1, 2008;
32(1):
243 - 244.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med.,
May 15, 2008;
177(10):
1068 - 1073.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Lim and C. Mottram
The Use of Fraction of Exhaled Nitric Oxide in Pulmonary Practice
Chest,
May 1, 2008;
133(5):
1232 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Michils, S. Baldassarre, and A. Van Muylem
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Eur. Respir. J.,
March 1, 2008;
31(3):
539 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bodini, D. Peroni, A. Loiacono, S. Costella, R. Pigozzi, E. Baraldi, A. L. Boner, and G. L. Piacentini
Exhaled Nitric Oxide Daily Evaluation Is Effective in Monitoring Exposure to Relevant Allergens in Asthmatic Children
Chest,
November 1, 2007;
132(5):
1520 - 1525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Exhaled Nitric Oxide Guidance for Asthma Management?
Journal Watch (General),
August 7, 2007;
2007(807):
3 - 3.
[Full Text]
|
 |
|

|
 |

|
 |
 
D. R. Taylor
Exhaled NO: Forward, Backward, or Sideways?
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
221 - 222.
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|